Is Contrast MRI Needed for SAPHO Diagnosis or Monitoring?
At a Glance
Contrast MRI is not always needed for SAPHO syndrome. Noncontrast MRI often shows active bone inflammation and chronic changes when monitoring known lesions. Gadolinium can help assess infection, tumor, abscess, or nerve problems, but MRI alone cannot confirm SAPHO.
In this answer
4 sections
A noncontrast MRI is often adequate to assess known bone and joint inflammation in SAPHO syndrome, meaning that an injection of gadolinium (the contrast dye used in MRI scans) is not always required [1]. However, an MRI alone cannot diagnose SAPHO syndrome; diagnosis depends on your complete clinical picture, skin findings, and ruling out other conditions [2].
Bottom line: Whether you need contrast depends on what your care team is trying to answer. A noncontrast scan is often useful for monitoring known inflammation, while contrast is more likely needed if your doctors are evaluating for infection, tumor, abscesses, or significant soft-tissue or neurological complications.
What Noncontrast MRI Can Show
For routine monitoring of known SAPHO lesions, a standard noncontrast MRI provides valuable information. Using standard imaging settings (which your radiologist might call T1 or fluid-sensitive sequences), an MRI can help identify:
- Active inflammation: Noncontrast scans are highly sensitive to bone-marrow edema (swelling inside the bone) and osteitis (bone inflammation) [3] [4].
- Chronic structural changes: An MRI without contrast can also show long-term changes, such as hyperostosis (excessive bone growth), bone bridging across joints, and fat infiltration where inflammation used to be [3]. (Note that CT scans are sometimes better than MRI at showing these hard, bony changes [5]).
Because these are hallmark features of SAPHO syndrome, a noncontrast scan is often a reasonable approach when the goal is to map out the disease or check if known lesions are currently active [6].
When Contrast (Gadolinium) Might Be Needed
While noncontrast scans are powerful, there are specific situations where the radiologist or ordering doctor will request gadolinium contrast. Contrast highlights areas with increased blood flow, which helps the medical team evaluate concerning features:
- Evaluating for infection or tumors: Because SAPHO lesions can mimic serious conditions like osteomyelitis (bone infection) or bone tumors, contrast can help characterize the tissue [7]. However, contrast cannot definitively rule these conditions out; sometimes biopsies, blood cultures, or follow-up imaging are still needed [8] [2]. (Note: Do not panic if your doctor mentions these possibilities—they are standard conditions to check for because SAPHO looks so similar to them).
- Evaluating soft-tissue complications: SAPHO syndrome can sometimes cause inflammation or fluid collections in the soft tissues adjacent to the bones (such as a suspected abscess in the muscles next to the spine). Contrast makes these soft-tissue complications easier to identify [9] [10].
- Spinal and neurological involvement: If SAPHO is affecting your spine, contrast can help doctors assess the surrounding tissues and nerve roots [9] [11].
Important: If you experience new weakness, loss of sensation, severe or rapidly worsening spinal pain, difficulty walking, or new loss of bladder or bowel control, seek emergency medical care immediately, regardless of any planned imaging appointments.
Safety Considerations: Kidneys and Pregnancy
If your doctor recommends contrast, they will evaluate whether it is safe for you based on your medical history.
- Kidney Function: Gadolinium contrast is cleared by your kidneys. The safety depends on your estimated glomerular filtration rate (eGFR) (a measure of kidney function) and the specific contrast agent being used. Modern “Group II” gadolinium agents have an incredibly low risk of complications (such as a rare skin and organ condition called Nephrogenic Systemic Fibrosis), even for patients with severe kidney disease (an eGFR below 30) [12] [13]. Your radiology team will review your eGFR and any history of acute kidney injury to choose the safest protocol.
- Pregnancy: Routine gadolinium is generally avoided during pregnancy. However, a Group II agent may still be considered if the expected diagnostic benefit substantially outweighs the uncertain risk to the fetus, and if no adequate alternative test exists [14] [15].
- Prior Reactions: Always tell your imaging team if you have ever had an allergic-like reaction to MRI contrast in the past, or if you have any implanted medical devices.
Who Makes the Decision?
The decision to use contrast is collaborative. Your specialist (like a rheumatologist) orders the scan, but the radiologist usually designs or approves the specific imaging protocol based on your symptoms and the clinical question. Discuss the plan with your care team so you understand exactly what they are looking for and why a specific type of scan was chosen.
Common questions in this guide
Do I need contrast MRI to diagnose SAPHO syndrome?
When is gadolinium recommended for SAPHO syndrome?
Is noncontrast MRI enough to monitor SAPHO lesions?
Is MRI contrast safe if I have kidney disease or might be pregnant?
What symptoms mean I should seek urgent care while being evaluated for SAPHO?
Who decides whether my SAPHO MRI needs contrast?
Related questions
Show more
Get notified when new evidence is published on SAPHO syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Pro and contra: is synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) a spondyloarthritis variant?
Furer V, Kishimoto M, Tomita T, et al.
Current opinion in rheumatology 2022; (34(4)):209-217 doi:10.1097/BOR.0000000000000884.
PMID: 35699334 - 2
SAPHO Syndrome Mimicking Infectious Spondylodiscitis and Bone Metastasis.
Biuden S, Maatallah K, Riahi H, et al.
Case reports in rheumatology 2021; (2021()):5577257 doi:10.1155/2021/5577257.
PMID: 34527384 - 3
Anterior chest wall in SAPHO syndrome: magnetic resonance imaging findings.
Yu M, Cao Y, Li J, et al.
Arthritis research & therapy 2020; (22(1)):216 doi:10.1186/s13075-020-02309-6.
PMID: 32928273 - 4
Multimodal imaging findings of SAPHO syndrome with no skin lesions: A report of three cases and review of the literature.
Duan N, Chen X, Liu Y, et al.
Experimental and therapeutic medicine 2016; (12(4)):2665-2670 doi:10.3892/etm.2016.3689.
PMID: 27698770 - 5
CT and MRI features of SAPHO syndrome: a report of 6 cases.
Xu K, Meng Y, Zuo T
BMC musculoskeletal disorders 2026; (27(1)).
PMID: 42260489 - 6
[SAPHO-Synovitis, acne, pustulosis, hyperosteosis, osteitis].
Hesse N, Hoppe B, Reidler P, Schmitt R
Radiologie (Heidelberg, Germany) 2025; (65(9)):681-687 doi:10.1007/s00117-025-01487-1.
PMID: 40694075 - 7
FDG PET/CT in Early and Late Stages of SAPHO Syndrome: Two Case Reports With MRI and Bone Scintigraphy Correlation.
Dong A, Bai Y, Cui Y, et al.
Clinical nuclear medicine 2016; (41(4)):e211-5 doi:10.1097/RLU.0000000000000983.
PMID: 26359576 - 8
[Pathophysiology and MRI Findings of Infectious Spondylitis and the Differential Diagnosis].
Ryu S, Kim YJ, Lee S, et al.
Taehan Yongsang Uihakhoe chi 2021; (82(6)):1413-1440 doi:10.3348/jksr.2021.0138.
PMID: 36238882 - 9
SAPHO Syndrome: Imaging Findings of Vertebral Involvement.
McGauvran AM, Kotsenas AL, Diehn FE, et al.
AJNR. American journal of neuroradiology 2016; (37(8)):1567-72 doi:10.3174/ajnr.A4736.
PMID: 27012293 - 10
A surgical case of abscess of the sternal region due to synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome.
Tada M, Uehara H, Ohyu T, Watanabe A
General thoracic and cardiovascular surgery cases 2023; (2(1)):73 doi:10.1186/s44215-023-00093-8.
PMID: 39517044 - 11
Hypertrophic Pachymeningitis Related Brain Infarction in Synovitis-Acne-Pustulosis-Hyperostosis Osteomyelitis Syndrome.
Yazawa Y, Itabashi R
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2021; (30(2)):105522 doi:10.1016/j.jstrokecerebrovasdis.2020.105522.
PMID: 33307288 - 12
Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.
Schieda N, Blaichman JI, Costa AF, et al.
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2018; (69(2)):136-150 doi:10.1016/j.carj.2017.11.002.
PMID: 29706252 - 13
Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.
Weinreb JC, Rodby RA, Yee J, et al.
Kidney medicine 2021; (3(1)):142-150 doi:10.1016/j.xkme.2020.10.001.
PMID: 33604544 - 14
First-Trimester Exposure to Gadolinium-based Contrast Agents: A Utilization Study of 4.6 Million U.S. Pregnancies.
Bird ST, Gelperin K, Sahin L, et al.
Radiology 2019; (293(1)):193-200 doi:10.1148/radiol.2019190563.
PMID: 31429682 - 15
Safety of Magnetic Resonance Imaging in Pregnancy.
Maralani PJ, Pai V, Ertl-Wagner BB
Radiologie (Heidelberg, Germany) 2023; (63(Suppl 2)):34-40 doi:10.1007/s00117-023-01207-7.
PMID: 37747489
This page explains when contrast MRI may be used in SAPHO syndrome for informational purposes only and does not replace medical advice. Your rheumatologist and radiologist can decide which scan is safest and most useful for you.